Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing

Alzheimer's disease (AD) is the most common cause of dementia among older people, and the prevalence of this disease is estimated to rise quickly in the upcoming years. Unfortunately, almost all of the drug candidates tested for AD until now have failed to exhibit any efficacy. Henceforth, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Uddin, Md. Sahab, Kabir, Md. Tanvir, Jeandet, Philippe, Mathew, Bijo, Ashraf, Ghulam Md, Perveen, Asma, Bin-Jumah, May N., Mousa, Shaker A., Abdel-Daim, Mohamed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206886/
https://www.ncbi.nlm.nih.gov/pubmed/32411333
http://dx.doi.org/10.1155/2020/7039138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206886/
https://www.ncbi.nlm.nih.gov/pubmed/32411333
http://dx.doi.org/10.1155/2020/7039138

Ejemplares similares